Insulin degludec injection, RD15003
RD15003-P-01
Phase 1 mab completed
Quick answer
Insulin degludec injection, RD15003 for Type 2 Diabetes is a Phase 1 program (mab) at Sunshine Biopharma with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Sunshine Biopharma
- Indication
- Type 2 Diabetes
- Phase
- Phase 1
- Modality
- mab
- Status
- completed